13th edition


December 3rd & 4th, 2024


December 11th& 12th 2024



Co-Founder, -CEO & CMO

Daniel joined the TVM Capital Life Science team as Executive-in-Residence based in Munich in September 2016.

He is responsible for deal sourcing, deal monitoring as well as transaction advisory. He is and was a member of the Board of Directors at leon-nanodrugs GmbH, Munich, Centogene AG, Rostock, MicrobeDx, Inc. Los Angeles, CA, Prothea-X Ltd, Edinburgh and is an observer to the Board of Directors at Mediti Pharma, Inc. Montreal, QC.

Daniel joined TVM from Novartis AG, where he spent 12 years in three Divisions including Pharma in Basel, Switzerland, Vaccines & Diagnostics in Emeryville, CA, USA and Sandoz (Generics / Biopharmaceuticals) in Holzkirchen / Munich, Germany. He held various line function across the three Businesses including Global Franchise Head Strategic Marketing for Immunology & Infectious Diseases in Pharma and Global Head of Development, Diagnostics. He oversaw and was a team member for multiple collaborations, licensing deals and acquisitions from academic to multi-billion dollar transactions, world-wide commercial launches and FDA / EMA / CFDA / ANVISA registrations with respective clinical trials.

Prior to Novartis he was at McKinsey & Company, Inc. and was trained as an MD at Johannes-Gutenberg-University Mainz, Germany with clinical training in Germany, Switzerland and the USA (UC Davis Medical Center, Sacramento, CA) and having been a scientific co-worker at the Institute for Occupational, Social and Environmental Medicine in Mainz for several years.

Scroll to Top
  • No products in the cart.